Back
CI Bio-Revolution Idx ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
55
CDNA.TO
CI Bio-Revolution Idx ETF
Last Price:
17.73
Seasonality Move:
-4.65%
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
49.00
Seasonality Move:
5.37%
Buy
55
CI Bio-Revolution Idx ETF (CDNA.TO)
is a Buy
Is CI Bio-Revolution Idx ETF a Buy, Sell or Hold?
- The current CI Bio-Revolution Idx ETF [CDNA.TO] share price is $17.73. The Score for CDNA.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CDNA.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $49.31. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDNA.TO Stock Price Chart
What is CI Bio-Revolution Idx ETF's stock price today?
-
The CI Bio-Revolution Idx ETF share price today is $17.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDNA.TO is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $49.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDNA.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 94.34 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.73 - 17.73) | Sell |
| Bollinger Bands (100): | (15.82 - 17.64) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 56.67 | Buy |
| Chaikin Money Flow: | 333879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.98 - 48.54) | Buy |
| Bollinger Bands (100): | (39.04 - 47.76) | Buy |
CDNA.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.73 | Sell |
| 20-day SMA: | 17.73 | Sell |
| 50-day SMA: | 17.45 | Buy |
| 200-day SMA: | 16.85 | Buy |
| 8-day EMA: | 17.73 | Buy |
| 20-day EMA: | 17.7 | Buy |
| 50-day EMA: | 17.44 | Buy |
| 200-day EMA: | 17.02 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.35 | Buy |
| 20-day SMA: | 47.19 | Buy |
| 50-day SMA: | 47.04 | Buy |
| 200-day SMA: | 42.95 | Buy |
| 8-day EMA: | 48.61 | Buy |
| 20-day EMA: | 47.6 | Buy |
| 50-day EMA: | 46.29 | Buy |
| 200-day EMA: | 41.02 | Buy |
CI Bio-Revolution Idx ETF Earnings Growth & CDNA.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
CI Bio-Revolution Idx ETF Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||